New diabetes clinical trial: SKYCLARYS® (Omaveloxolone) Pregnancy and Lactation Surveillance Program

Published on: October 06, 2024 at 11:00PM
Conditions: Friedreich Ataxia
Interventions: Drug: Omaveloxolone
Sponsors: Reata, a wholly owned subsidiary of Biogen
Not yet recruiting
https://ift.tt/KDQskOt